Patient Resources

Cannabis-based medicine in spasticity caused by multiple sclerosis

Sativex in patients suffering from multiple sclerosis associated detrusor overactivity

The effect of cannabis on urge incontinence in patients with multiple sclerosis

Nabilone significantly reduces spasticity-related pain

Cannabinoids in multiple sclerosis (CAMS) study

Sativex produced significant improvements in a subjective measure of spasticity

Cannabis-based medicine in central pain in multiple sclerosis.

Do cannabis-based medicinal extracts have general or specific effects

Efficacy, safety and tolerability of an oral cannabis extract in the treatment of spasticity

cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis.

Are oral cannabinoids safe and effective in refractory neuropathic pain?

Dronabinol in the treatment of agitation in patients with Alzheimer’s disease with anorexia

Cannabis based medicinal extracts (CBME) in central neuropathic pain due to multiple sclerosis.

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis

Cannabis based medicinal extract on refractory lower urinary tract dysfunction

Analgesic effect of the cannabinoid analogue nabilone

The perceived effects of smoked cannabis on patients with multiple sclerosis.

Orally and rectally administered delta-9-tetrahydrocannabinol on spasticity

Nabilone in the treatment of multiple sclerosis

Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.

Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.

Tetrahydrocannabinol for tremor in multiple sclerosis.

Marihuana as a therapeutic agent for muscle spasm or spasticity

Cannabis-based medicine in spasticity caused by multiple sclerosis.

Cannabis based treatments for neuropathic and multiple sclerosis-related pain.

The effect of cannabis on urge incontinence in patients with multiple sclerosis

Cannabis' Potential Exciting Researchers in Treatment of ALS, Parkinson's Disease

The endocannabinoid system is dysregulated in multiple sclerosis

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

Nabilone The synthetic cannabinoid nabilone improves pain and symptom management in cancer patients

Nabilone versus prochlorperazine

Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases.

Nausea relieved by tetrahydrocannabinol (dronabinol).

An efficient new cannabinoid antiemetic in pediatric oncology.

Effect of nabilone on nausea and vomiting after total abdominal hysterectomy.

Marijuana as antiemetic medicine

Efficacy of tetrahydrocannabinol in patients refractory to standard anti-emetic therapy

Inhalation marijuana as an antiemetic for cancer chemotherapy.

Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children

Acute and subacute bronchial effects of oral cannabinoids.

Nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.

Nabilone vs. placebo in chemotherapy-induced nausea and vomiting.

Dose vs response of tetrahydroannabinol (THC) vs prochlorperazinedelta 9-

Comparative trial of the antiemetic effects of THC and haloperidol

Comparison of delta-9- tetrahydrocannabinol and prochlorperazine.

Tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications.

Antiemetic effect of tetrahydrocannabinol

The antiemetic activity of tetrahydrocanabinol versus metoclopramide and thiethylperazine

The antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.

Delta-9- tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy

Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9- THC.

Superiority of nabilone over prochlorperazine as an antiemetic

Antiemetic effect of delta-9- tetrahydrocannabinol in patients receiving cancer chemotherapy.

Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids

The Endocannabinoid-CB Receptor System

Ganja use among Jamaican women.

Dreher's Jamaican Pregnancy Study

Nonmutagenic action of cannabinoids in vitro

Prenatal exposure to tobacco, alcohol, cannabis and caffeine on birth size and subsequent growth.

Tobacco and marijuana use on offspring growth from birth through 3 years of age.

Prenatal marijuana use and neonatal outcome.

Topical cannabinoid agonists : An effective new possibility for treating chronic pruritus.

Dronabinol in patients with intractable pruritus secondary to cholestatic liver disease.

Cannabidiol as an antipsychotic

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients

Delta-9- Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition

Cannabis does not induce schizophrenia,

Cannabis use does not cause schizophrenia

Cannabinoids and psychosis.

Cannabis as a psychotropic medication

Study Shows Long Term Marijuana Users Healthy

Cannabis and schizophrenia link blurs further

Dronabinol reduces signs and symptoms of idiopathic intracranial hypertension

Cannabis-based medicine in central pain in multiple sclerosis.

Two cannabis based medicinal extracts for relief of central neuropathic pain

Functional role for cannabinoids in respiratory stability during sleep

THC reduces sleep apnoea in animal research

Cannabis-based medicine in spasticity caused by multiple sclerosis

Cannabinoids in multiple sclerosis

Sativex produced significant improvements in a subjective measure of spasticity

Do cannabis-based medicinal extracts have general or specific effects on symptoms in ms?

Efficacy, safety and tolerability of an oral cannabis extract in the treatment of spasticity

Are oral cannabinoids safe and effective in refractory neuropathic pain?

Experiences with THC-treatment in children and adolescents

The treatment of spasticity with D9-THC in patients with spinal cord injury

The effect of orally and rectally administered delta-9- tetrahydrocannabinol on spasticity

Nabilone in the treatment of multiple sclerosis.

Treatment of spasticity in spinal cord injury with dronabinol

Delta-9- tetrahydrocannabinol shows antispastic and analgesic effects

Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.

Delta-9- THC in the treatment of spasticity associated with multiple sclerosis.

Effect of Delta-9- THC on EMG Measurements in Human Spasticity Smoked marijuana and oral delta-9- THC on specific airway conductance in asthmatic subjects

Delta(9)-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.

9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer

THC and prochlorperazine effective in reducing vomiting in women following breast surgery

{Delta}9-Tetrahydrocannabinol- Induced Apoptosis in Jurkat Leukemia T Cells

Delta(9)-THC) prevents cerebral infarction

Medical marijuana: study shows that THC slows atherosclerosis

Delta-9- tetrahydrocannabinol shows antispastic and analgesic effects

The effect of delta-9- THC on human spasticity.

The treatment of spasticity with D9-THC) in patients with spinal cord injury

Delta-9- THC as an alternative therapy for overactive bladders in spinal cord injury

The effect of orally and rectally administered delta-9- tetrahydrocannabinol on spasticity

The treatment of spasticity with Delta(9)-tetrahydrocannabinol in persons with spinal cord injury.

Delta-9- Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition